Katarina Luptakova - CHIEF MEDICAL OFFICER at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
XLO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Katarina Luptakova since 23 Feb 2025

Holdings reported by Katarina Luptakova for Xilio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 33,250 $49,062 $0.9837 01 Jan 2026 Direct Common Stock
Common Stock 33,250 $23,940 $0.7200 01 Jan 2026 Direct
Stock Option (right to buy) 451,885 31 Dec 2025 Direct Common Stock

Transactions reported by Katarina Luptakova for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.